Updated Jul 16, 2026
Cobb Stuart is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $141K.

Stuart Cobb is a prominent scientist and executive in the biotechnology sector, currently serving as the Chief Scientific Officer at Neurogene Inc. He has extensive experience in gene therapy and has contributed significantly to the development of innovative treatments for genetic disorders. His work has been recognized in various scientific publications and conferences.
| Role | Chief Scientific Officer |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-17 | NGNE | Neurogene Inc. | S — Open-market sale [10b5-1] | 148 | $22.08 | $3K |
| 2026-03-17 | NGNE | Neurogene Inc. | S — Open-market sale [10b5-1] | 2.7K | $21.34 | $57K |
| 2026-03-17 | NGNE | Neurogene Inc. | S — Open-market sale [10b5-1] | 4.0K | $20.41 | $81K |
| 2026-02-24 | NGNE | Neurogene Inc. | A — Grant or award | 16.5K | $0.00 |
Stuart Cobb is a prominent scientist and executive in the biotechnology sector, currently serving as the Chief Scientific Officer at Neurogene Inc. He has extensive experience in gene therapy and has contributed significantly to the development of innovative treatments for genetic disorders. His work has been recognized in various scientific publications and conferences.…
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($141K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cobb Stuart profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.